Mark Israel named executive director of Israel Cancer Research Fund

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Mark Israel, a pediatric oncologist and translational scientist, was appointed national executive director of the Israel Cancer Research Fund, a nonprofit organization dedicated solely to funding cancer research in Israel.

Israel joins ICRF from the Geisel School of Medicine at Dartmouth College, where he is a professor in the Department of Pediatrics, Medicine, and Molecular and Systems Biology. From 2001 to 2016, Israel served as the director of Dartmouth’s Norris Cotton Cancer Center.

For the last 12 years, Israel has been a volunteer member of the ICRF’s scientific review panel and the chair of the panel that evaluates translational cancer research proposals.

“Cancer research has never been more exciting or promising—and that is particularly true in Israel,” Israel said in a statement. “Israeli science knows no bounds. ICRF provides a singular opportunity to help build more recognition and support for the world-class cancer research of Israeli scientists, and to arm and empower its finest practitioners with the resources necessary to change the world.”

Table of Contents

YOU MAY BE INTERESTED IN

For decades, we have faced a central challenge in colorectal cancer screening. One in three eligible Americans—over 50 million people—remain unscreened despite established methods like colonoscopy or stool-based tests existing for decades. This gap persists even though early detection saves lives, and even as colorectal cancer is now the number one cancer killer for Americans under 50.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login